LMAT

Lemaitre Vascular Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth 4/10
  • Momentum 4/10
Lemaitre Vascular sales and earnings growth
LMAT Growth
Neutral
  • Revenue Y/Y 13.07%
  • EPS Y/Y 27.42%
  • FCF Y/Y 97.74%
Lemaitre Vascular gross and profit margin trends
LMAT Profitability
Great
  • Gross margin 71.00%
  • EPS margin 22.10%
  • ROIC 12.10%
Lemaitre Vascular recent dividend growth
LMAT Dividends
  • Dividend yield 0.88%
  • Growth 3Y 18.09%
  • Payout ratio 32%
Lemaitre Vascular net debt vs free cash flow
LMAT Risk
Great
  • Debt / Equity 0.5
  • Debt / FCF 2.4
  • Interest coverage 17.8

Lemaitre Vascular stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗